Cormorant Asset Management, LP Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$2.6T
Holdings
90
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (90 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —TURNING POINT THERAPEUTICS I | 2,442,297 | $213.4B | 8.20% | |
| 2 | SPYSPDR S&P 500 ETF TR | 500,000 | $167.4B | 6.44% | Put |
| 3 | —FORMA THERAPEUTICS HLDGS INC | 3,379,373 | $166.5B | 6.40% | |
| 4 | RVMDREVOLUTION MEDICINES INC | 2,640,177 | $91.9B | 3.53% | |
| 5 | CCXIEURCHEMOCENTRYX INC | 1,650,000 | $90.4B | 3.48% | Call |
| 6 | BBIOBRIDGEBIO PHARMA INC | 2,265,762 | $85.0B | 3.27% | |
| 7 | IWMISHARES TR | 500,000 | $74.9B | 2.88% | Put |
| 8 | SRNESORRENTO THERAPEUTICS INC | 6,500,000 | $72.5B | 2.79% | Call |
| 9 | RNAAVIDITY BIOSCIENCES INC | 2,514,546 | $69.5B | 2.67% | |
| 10 | —MYOKARDIA INC | 450,000 | $61.3B | 2.36% | |
| 11 | OMEROMEROS CORP | 6,000,000 | $60.6B | 2.33% | Call |
| 12 | IMVTIMMUNOVANT INC | 1,637,951 | $57.6B | 2.22% | |
| 13 | APLSAPELLIS PHARMACEUTICALS INC | 1,866,108 | $56.3B | 2.16% | |
| 14 | XLRNACCELERON PHARMA INC | 500,000 | $56.3B | 2.16% | |
| 15 | XBISPDR SER TR | 500,000 | $55.7B | 2.14% | Put |
| 16 | YMABUSDY-MABS THERAPEUTICS INC | 1,397,700 | $53.7B | 2.06% | |
| 17 | —ZYMEWORKS INC | 1,150,000 | $53.6B | 2.06% | |
| 18 | STOKSTOKE THERAPEUTICS INC | 1,537,807 | $51.5B | 1.98% | |
| 19 | —EIDOS THERAPEUTICS INC | 993,185 | $50.2B | 1.93% | |
| 20 | MRTXEURMIRATI THERAPEUTICS INC | 275,000 | $45.7B | 1.76% | |
| 21 | —VIELA BIO INC | 1,585,000 | $44.5B | 1.71% | |
| 22 | RETAEURREATA PHARMACEUTICALS INC | 450,000 | $43.8B | 1.69% | |
| 23 | TWSTTWIST BIOSCIENCE CORP | 500,000 | $38.0B | 1.46% | |
| 24 | ALXOALX ONCOLOGY HLDGS INC | 971,770 | $36.0B | 1.38% | |
| 25 | TREURTRILLIUM THERAPEUTICS INC | 2,500,000 | $35.5B | 1.37% | |
| 26 | AXNX*AXONICS MODULATION TECHNOLOG | 693,000 | $35.4B | 1.36% | |
| 27 | AGENEURAGENUS INC | 8,500,000 | $34.0B | 1.31% | |
| 28 | —BIOHAVEN PHARMACTL HLDG CO L | 500,000 | $32.5B | 1.25% | |
| 29 | RCKTROCKET PHARMACEUTICALS INC | 1,368,550 | $31.3B | 1.20% | |
| 30 | ARCTARCTURUS THERAPEUTICS HLDGS | 700,000 | $30.0B | 1.15% | |
| 31 | —MYOVANT SCIENCES LTD | 2,134,966 | $30.0B | 1.15% | |
| 32 | AKROAKERO THERAPEUTICS INC | 859,550 | $26.5B | 1.02% | |
| 33 | 2L9BLUEPRINT MEDICINES CORP | 275,000 | $25.5B | 0.98% | |
| 34 | CRSPCRISPR THERAPEUTICS AG | 300,000 | $25.1B | 0.96% | |
| 35 | BDQMALBIREO PHARMA INC | 700,000 | $23.4B | 0.90% | |
| 36 | BNTXBIONTECH SE | 325,000 | $22.4B | 0.86% | |
| 37 | CABACABALETTA BIO INC | 2,067,302 | $22.4B | 0.86% | |
| 38 | BEAMBEAM THERAPEUTICS INC | 796,428 | $19.6B | 0.75% | |
| 39 | ASNDASCENDIS PHARMA A/S | 125,000 | $19.3B | 0.74% | |
| 40 | GLPGGALAPAGOS NV | 130,000 | $18.5B | 0.71% | |
| 41 | AXSMAXSOME THERAPEUTICS INC | 250,000 | $17.8B | 0.68% | |
| 42 | 1K0IGM BIOSCIENCES INC | 225,000 | $16.6B | 0.64% | |
| 43 | ZLABZAI LAB LTD | 189,092 | $15.7B | 0.60% | |
| 44 | INSPINSPIRE MED SYS INC | 120,000 | $15.5B | 0.60% | |
| 45 | KURAKURA ONCOLOGY INC | 500,000 | $15.3B | 0.59% | |
| 46 | PLRXPLIANT THERAPEUTICS, INC | 611,409 | $13.6B | 0.52% | |
| 47 | OTICEUROTONOMY INC | 3,241,800 | $13.1B | 0.50% | |
| 48 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 250,000 | $12.8B | 0.49% | |
| 49 | —TCR2 THERAPEUTICS INC | 600,000 | $12.2B | 0.47% | |
| 50 | QUREUNIQURE NV | 325,000 | $12.0B | 0.46% | |
| 51 | SRPTSAREPTA THERAPEUTICS INC(NSM) | 85,000 | $11.9B | 0.46% | |
| 52 | IM8NINSMED INC | 350,000 | $11.2B | 0.43% | |
| 53 | —AKOUOS INC | 499,991 | $11.2B | 0.43% | |
| 54 | RPTXREPARE THERAPEUTICS INC | 348,567 | $10.7B | 0.41% | |
| 55 | ARGXARGENX SE | 40,000 | $10.5B | 0.40% | |
| 56 | —QUOTIENT LTD | 2,000,000 | $10.3B | 0.40% | |
| 57 | —HARPOON THERAPEUTICS INC | 570,600 | $9.7B | 0.37% | |
| 58 | TBPHTHERAVANCE BIOPHARMA INC | 650,072 | $9.6B | 0.37% | |
| 59 | ANABANAPTYSBIO INC | 650,000 | $9.6B | 0.37% | |
| 60 | —HEALTH SCIENCES ACQ CORP 2 | 800,000 | $8.8B | 0.34% | |
| 61 | 5E7ITEOS THERAPEUTICS INC | 350,000 | $8.6B | 0.33% | |
| 62 | —BCTG ACQUISITION CORP | 800,000 | $8.4B | 0.32% | |
| 63 | TARAPROTARA THERAPEUTIC INC | 450,000 | $7.6B | 0.29% | |
| 64 | —THERAPEUTICS ACQUISITION COR | 500,000 | $7.2B | 0.28% | |
| 65 | MORFMORPHIC HLDG INC | 250,000 | $6.8B | 0.26% | |
| 66 | 1T7TRICIDA INC | 727,975 | $6.6B | 0.25% | |
| 67 | ALLKGUSDALLAKOS INC | 75,000 | $6.1B | 0.23% | |
| 68 | —GENETRON HLDGS LTD | 500,000 | $6.0B | 0.23% | |
| 69 | 0HJQAVEO PHARMACEUTICALS INC | 1,000,000 | $5.9B | 0.23% | |
| 70 | —FS DEV CORP | 500,000 | $5.6B | 0.22% | |
| 71 | MRUSMERUS N V | 429,284 | $5.2B | 0.20% | |
| 72 | FIXXEURHOMOLOGY MEDICINES INC | 470,897 | $5.0B | 0.19% | |
| 73 | AUTLAUTOLUS THERAPEUTICS PLC | 422,167 | $4.9B | 0.19% | |
| 74 | KZRKEZAR LIFE SCIENCES INC | 931,800 | $4.5B | 0.17% | |
| 75 | —VESPER HEALTHCARE ACQSTN COR | 400,000 | $4.1B | 0.16% | |
| 76 | BCELATRECA INC | 293,500 | $4.1B | 0.16% | |
| 77 | —KADMON HOLDINGS INC | 1,000,000 | $3.9B | 0.15% | |
| 78 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 449,510 | $3.7B | 0.14% | |
| 79 | —AVROBIO INC | 244,032 | $3.2B | 0.12% | |
| 80 | GOSSGOSSAMER BIO INC | 248,382 | $3.1B | 0.12% | |
| 81 | —PANACEA ACQUISITION CORP | 250,000 | $3.0B | 0.12% | |
| 82 | CRDFCARDIFF ONCOLOGY INC | 175,000 | $2.5B | 0.10% | |
| 83 | ARNAEURARENA PHARMACEUTICALS INC | 30,000 | $2.2B | 0.09% | |
| 84 | DTILPRECISION BIOSCIENCES INC | 346,524 | $2.1B | 0.08% | |
| 85 | AMRNAMARIN CORP PLC | 300,000 | $1.3B | 0.05% | |
| 86 | ORTXUSDORCHARD THERAPEUTICS PLC | 256,649 | $1.1B | 0.04% | |
| 87 | NKTREURNEKTAR THERAPEUTICS | 50,000 | $830.0M | 0.03% | |
| 88 | NERVGBPMINERVA NEUROSCIENCES INC | 238,817 | $759.0M | 0.03% | |
| 89 | FATEFATE THERAPEUTICS INC | 15,000 | $600.0M | 0.02% | |
| 90 | —OUTLOOK THERAPEUTICS INC | 416,666 | $54.0M | 0.00% |